Breaking News
Get 60% Off 0
Cyber Monday Deal: Up to 60% off InvestingPro
CLAIM SALE
Close

Eidos Therapeutics Inc (EIDX)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Eidos Therapeutics's earnings

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
Eidos Therapeutics historical data, for real-time data please try another search
122.21 0.00    0.00%
25/01 - Real-time Cboe. Currency in USD
Type:  Equity
Market:  United States
  • Volume: 0
  • Bid/Ask: 0.00 / 0.00
  • Day's Range: 116.83 - 128.49
Eidos Therapeutics 122.21 0.00 0.00%

EIDX Recent Sentiments

 
This page features our users' sentiments regarding the Eidos Therapeutics Inc Share. They are displayed on both charts of different time periods and in a detailed table.
Start Date Username Call Open Rate End Date Percentage Change
Jun 13, 2024 harald caluwaerts   122.21 Jun 17, 2024 @ 122.21 0.00%
Oct 06, 2020 Mattia Melissano   73.08 Oct 30, 2020 @ 70.80 -3.12%
Oct 05, 2020 Alex Preda   73.55 Oct 30, 2020 @ 70.80 +3.74%
Oct 05, 2020 ויטלי קורדובה   73.92 Oct 30, 2020 @ 70.80 -4.22%
Oct 05, 2020 Yogesh Surve   73.23 Oct 30, 2020 @ 70.80 +3.32%
Oct 05, 2020 Marwan Qureshi   73.17 Oct 30, 2020 @ 70.80 -3.24%
Oct 05, 2020 waleed ba   68.43 Oct 05, 2020 @ 72.49 -5.93%
Feb 11, 2020 Super29 Btt   54.78 Mar 06, 2020 @ 48.30 -11.83%
Jan 15, 2020 Super29 Btt   55.95 Feb 07, 2020 @ 53.19 -4.93%
Jan 09, 2020 Ali Akkor   57.70 Jan 31, 2020 @ 53.28 -7.66%
Jan 09, 2020 Rich Judd   57.59 Jan 10, 2020 @ 55.00 -4.50%
Dec 11, 2019 Lily Guan   64.12 Jan 03, 2020 @ 56.66 -11.63%
Dec 11, 2019 Super29 Btt   61.95 Jan 03, 2020 @ 56.66 -8.54%
Dec 02, 2019 Roman Podlesnyy   55.81 Dec 27, 2019 @ 58.61 +5.02%
Nov 19, 2019 Joshua McElmurray   58.40 Dec 13, 2019 @ 63.50 +8.73%
Aug 30, 2019 Константин Пастухов   41.87 Sep 20, 2019 @ 41.29 -1.39%
Aug 12, 2019 Super29 Btt   37.71 Sep 06, 2019 @ 41.91 +11.14%
Jun 13, 2019 Mark Stone   31.98 Jul 05, 2019 @ 36.62 +14.51%
May 08, 2019 fred clarke   25.88 May 31, 2019 @ 31.21 +20.60%
Apr 29, 2019 Jonas Binder   27.25 May 24, 2019 @ 29.64 +8.77%
Apr 23, 2019 Fabio Ferrieri   27.41 Apr 30, 2019 @ 26.21 +4.38%
Nov 12, 2018 Kevin Hoang   13.81 Dec 12, 2018 @ 0.00 -100.00%
Nov 12, 2018 Hermann Albrecht   12.71 Nov 12, 2018 @ 13.99 +10.07%
Nov 01, 2018 Azeem Lawal   13.02 Dec 01, 2018 @ 0.00 -100.00%
Oct 04, 2018 Olivier Boulogne   9.20 Nov 03, 2018 @ 0.00 -100.00%
Sep 11, 2018 Smet Kaskabassov   12.15 Oct 11, 2018 @ 0.00 -100.00%
Aug 27, 2018 Christopher Dayon   14.08 Sep 26, 2018 @ 9.92 +29.55%
Aug 27, 2018 Tibi Oprea   14.23 Sep 26, 2018 @ 9.92 -30.29%
Aug 27, 2018 zufar ihsan   13.57 Sep 26, 2018 @ 9.92 +26.90%
Aug 27, 2018 Anita Vacca   12.10 Sep 06, 2018 @ 11.94 +1.32%
Aug 06, 2018 Smet Kaskabassov   17.71 Sep 05, 2018 @ 11.94 -32.58%
Jun 20, 2018 Joey Falcone   21.62 Jul 20, 2018 @ 21.28 -1.57%
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

EIDX Comments

Write your thoughts about Eidos Therapeutics Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Apple
Continue with Google
or
Sign up with Email